Haemonetics Corporation Financial Results Overview
Haemonetics Corporation (NYSE: HAE) has recently announced that its financial results for the second quarter of fiscal year 2026 are now accessible online. This comes after the quarter concluded on September 27, 2025, and represents a significant period of growth and evaluation for the company.
Online Availability of Financial Release
Investors can find the comprehensive financial release and an accompanying supplemental presentation on the company's Investor Relations website. This is part of Haemonetics’ commitment to transparency and keeping its stakeholders informed about its financial health and operational milestones.
Conference Call Details
The Company has scheduled a conference call and webcast to engage with investors and analysts regarding the results. The event is set for 8:00 a.m. ET on November 6, 2025. This is an opportunity for participants to gain insights and seek clarifications regarding the financial results released.
How to Participate
To participate in the conference call and webcast, investors must register beforehand. Upon completing the registration process, attendees will receive dial-in details and a personalized PIN, ensuring a streamlined experience. It's suggested that participants join the call 10 minutes early to prepare.
Accessing the Webcast
A live webcast will be available, allowing investors to tune into the call from any location. This format facilitates broader participation, offering an accessible platform for individuals who may not be able to attend in person.
Replay Option for Investors
For those unable to attend the live conference, a replay will be made available starting at 11:00 a.m. ET on the same day. The recording will remain accessible for one year, ensuring that all interested parties can review the discussion at their convenience.
Additional Information Available
Alongside the financial results, Haemonetics will share several important materials related to the earnings call. This includes the Second Quarter Fiscal 2026 Earnings Release and a Supplemental Earnings Presentation, both vital for a thorough understanding of the company's performance during this period.
About Haemonetics Corporation
Haemonetics is a leading global medical technology company that focuses on enhancing the efficiency and quality of health care through innovative solutions. These solutions encompass advanced hospital technologies, plasma collection systems, and blood component collection products designed to meet critical medical needs.
Contact Information for Investors
Investors seeking more information can reach out to Olga Guyette, Vice President of Investor Relations, or David Trenk, Manager of Investor Relations, via phone or email. They are available to provide additional insights on the company's financial results and strategies moving forward.
Media Inquiries
For media-related questions, Josh Gitelson, the Senior Director of Global Communications, is the point of contact. He is prepared to address media inquiries and provide relevant updates regarding company operations, innovations, and market strategies.
Frequently Asked Questions
What were the key financial highlights for Q2 Fiscal 2026?
The financial highlights for Q2 reflect various growth metrics, which can be explored in detail on the company's Investor Relations website.
How can I access the webcast for the conference call?
You can register for and access the live webcast through the Haemonetics Investor Relations page where the event will be streamed.
Is there a way to replay the conference call after it has concluded?
A replay will be available starting at 11:00 a.m. ET on the day of the call and will remain accessible for one year.
Who should I contact for investor-related questions?
You can contact Olga Guyette or David Trenk through the provided contact information for any investor queries.
What does Haemonetics focus on?
Haemonetics specializes in medical technologies that enhance healthcare outcomes, particularly in blood management and plasma collection.
